Generic Name: FLUTICASONE HFA INHALER - ORAL Pronounced: (floo-TIK-a-sone) Flovent HFA Inhl Uses
Fluticasone is used to control and prevent symptoms (such
as wheezing and shortness of breath) caused by asthma. It works by reducing
swelling (inflammation) of the airways in the lungs to make breathing easier.
Controlling symptoms of asthma helps you maintain your normal activities and
decreases time lost from work or school. Fluticasone belongs to a class of
drugs known as corticosteroids.
This medication must be used regularly to be effective. It
does not work immediately and should not be used to relieve sudden asthma
attacks. If an asthma attack occurs, use your quick-relief inhaler (such as
albuterol, also called salbutamol in some countries) as
How To Use Flovent HFA Inhl
Read the Patient Information Leaflet that comes with this
product before you start using fluticasone and each time you get a refill. Read
How will asthma care and health be affected by the economy? It is clear that we are in the midst of difficult economic times. Some of us can no longer bear to even pay attention to the changes in the stock market and the effect it is having on our savings. More importantly, the economic slowdown will cause job losses, and with them, loss of health insurance coverage. For many asthma sufferers, this will have an impact on being able to keep asthma under control, from being able to afford regular doctor appointments to affording quick-relief and controller medications . In addition, some individuals will need to move to a different housing arrangement. This may lead to more difficult trigger control as the home environment is an important factor in asthma control.
The economic slowdown will also have an impact on the role that public and non-profit resources play in controlling asthma. City and state governments across the country are already facing budget shortfalls and mandates t...
The phrase "reactive airways dysfunction syndrome" (RADS) denotes the development of a persistent asthma -like condition with airway hyper-responsiveness developing in a previously healthy asymptomatic individual within 24 hours of a single exposure to concentrated respiratory irritants. Not all experts are certain that RADS and a close counterpart, irritant-induced asthma (IIA), are real clinical entities. Recently, a state-of-the-art review concluded with some reservation that airway-hyper-responsiveness may be acquired as a result of non-immunogenic irritant exposures. Yet no published article on RADS or IIA has provided measurements of airway responsiveness obtained before an incriminated exposure incident, and none has quantified the intensity of the exposures. Taken in its entirety, the current scientific evidence supports the conclusion that RAD and IIA are valid clinical disorders. Respiratory irritants can lead to asthma and rhinitis through interaction with chemical ir...
You should knowAnswers to your question are meant to provide general health information but should not replace medical advice you receive from a doctor. No answers should be viewed as a diagnosis or recommended treatment for a condition. Content posted by community members does not necessarily reflect the views of Remedy Health Media, which also reserves the right to remove material deemed inappropriate.